Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06446648
What this trial is testing

Impact of Intraoperative ICG on Functional Outc in RARP

Who this might be right for
Prostate Adenocarcinoma
University of California, Irvine 400
Not applicableStudy completedNCT03064308
What this trial is testing

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

Who this might be right for
Impaired CognitionQuality of LifeSurgery+7 more
University of Nottingham 11
Testing effectiveness (Phase 2)Ended earlyNCT04616547
What this trial is testing

Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Adenocarcinoma+3 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT00005048
What this trial is testing

Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
NYU Langone Health
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Testing effectiveness (Phase 2)Study completedNCT01696877
What this trial is testing

A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma in Situ
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 29
Testing effectiveness (Phase 2)Study completedNCT07568444
What this trial is testing

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Bladder CancerKidney Cancers+1 more
University of Southern California 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07574489
What this trial is testing

Whole Versus Partial Gland Boost During Prostate SBRT

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Nebraska 186
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT05998278
What this trial is testing

Personalized Optimization of Systematic Prostate Biopsy

Who this might be right for
Prostate Adenocarcinoma
Fujian Medical University Union Hospital 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT04045717
What this trial is testing

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

Who this might be right for
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Universitaire Ziekenhuizen KU Leuven 124
Not applicableLooking for participantsNCT07115914
What this trial is testing

PSMA PET for Surveillance After Focal Therapy

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)Prostate Cancer Metastatic Disease
University of Chicago 62
Not applicableStudy completedNCT01856855
What this trial is testing

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)

Who this might be right for
Prostate CancerProstate AdenocarcinomaRadiation Toxicity+1 more
John Fiveash, MD 26
Not applicableTemporarily pausedNCT04955808
What this trial is testing

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

Who this might be right for
Breast CarcinomaColon CarcinomaInvasive Carcinoma+5 more
National Cancer Institute (NCI) 2,400
Not applicableEnded earlyNCT02454517
What this trial is testing

Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7
Fred Hutchinson Cancer Center 117
Not applicableNot Yet RecruitingNCT07460726
What this trial is testing

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Erectile AbnormalitiesSexual Dysfunction Male
CancerCare Manitoba 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Not applicableStudy completedNCT01857908
What this trial is testing

A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone

Who this might be right for
Prostate Cancer (Adenocarcinoma)
University Health Network, Toronto 20
Next Page